SCHEMBL7959152

SCHEMBL7959152

CC1(C)O[C@H]2[C@@H](O1)[C@@H](COCc1ccccc1)O[C@@H](Oc1ccc([N+](=O)[O-])cc1)[C@@H]2OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.55
ALDH1A1 P00352 2/20 0.41
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
SSTR1 P30872 1/20 0.36
SSTR2 P30874 1/20 0.36
SSTR4 P31391 1/20 0.36
SSTR3 P32745 1/20 0.36
SSTR5 P35346 1/20 0.36
PTPN1 P18031 6/20 0.35
CDC25B P30305 4/20 0.35
GJB2 P29033 1/20 0.35
HTR1A P08908 1/20 0.35
PTPN2 P17706 2/20 0.35
PTPN11 Q06124 2/20 0.35
HTT P42858 1/20 0.35
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
PTPN6 P29350 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958119 0.94 NT5E (0.54) NT5EALDH1A1CA1CA2CA9
SCHEMBL7957838 0.93 NT5E (0.47) NT5EALDH1A1SSTR1SSTR2SSTR4
SCHEMBL7957505 0.90 NT5E (0.47) NT5EALDH1A1HTT
SCHEMBL7955551 0.89 NT5E (0.45) NT5EALDH1A1SSTR1SSTR2SSTR4
SCHEMBL11886555 0.88 SSTR1 (0.40) NT5EALDH1A1SSTR1SSTR2SSTR4
SCHEMBL7955324 0.87 NT5E (0.43) NT5EALDH1A1HTT
SCHEMBL7948307 0.85 NT5E (0.64) NT5ECA1CA2CA9SSTR1
SCHEMBL7948306 0.85 NT5E (0.64) NT5ECA1CA2CA9SSTR1
SCHEMBL7955867 0.83 NT5E (0.61) NT5ESSTR4PTPN1CDC25BGJB2
SCHEMBL7955866 0.83 NT5E (0.61) NT5ESSTR4PTPN1CDC25BGJB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271342-B1 SERUM STABILITY; FOR TUMOR THERAPY BAYER AKTIENGESELLSCHAFT (DE) 2001-08-07 US disclosed
EP-0819135-B1 SUGAR-MODIFIED CYTOSTATICS BAYER AG (DE) 1999-11-17 EP disclosed